Finance

Beta
Lists
7EY:FRA
Kiora Pharmaceuticals Inc
0.00%
(0.00) 1D
Jul 17, 10:56:45 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 7EY...
Mkt. cap
11.66M
Volume
0.00
52-wk high
€0.42
52-wk low
€0.42
No. of employees
13
Mkt. cap
11.66M
Volume
0.00
52-wk high
€0.42
52-wk low
€0.42
No. of employees
13
News stories
From sources across the web
About Kiora Pharmaceuticals Inc
CEO-
Employees13
Founded1998
HeadquartersEncinitas, California, United States
SectorPharmaceutical industry
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
904.57K
1.07M
1.17M
890.50K
Cost of revenue
904.57K
1.07M
1.17M
890.50K
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.35M
1.44M
1.46M
1.61M
Operating expense
1.35M
1.44M
1.46M
1.61M
Total operating expenses
2.26M
2.52M
2.63M
2.50M
Operating income
-2.26M
-2.52M
-2.63M
-2.50M
Other non operating income
-93.56K
-23.71K
173.24K
-47.13K
EBT including unusual items
-2.26M
-616.32K
-7.17M
-2.42M
EBT excluding unusual items
-2.13M
-2.34M
-2.49M
-2.41M
Income tax expense
-112.06K
-643.13K
-649.97K
-
Effective tax rate
4.95%
104.35%
9.07%
-
Other operating expenses
-
-
-
-
Net income
-2.15M
26.81K
-6.52M
-2.42M
Net profit margin
-
-
-
-
Earnings per share
-0.54
0.01
-
-
Interest and investment income
225.24K
201.82K
190.31K
139.34K
Interest expense
-
-
-19.96K
-
Net interest expenses
225.24K
201.82K
170.35K
139.34K
Depreciation and amortization charges
-
-
-
-
EBITDA
-2.25M
-2.50M
-2.62M
-2.49M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more